81
Views
6
CrossRef citations to date
0
Altmetric
Drug Profile

Pemetrexed–cisplatin combination in mesothelioma

&
Pages 231-237 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ranjit K Goudar. (2008) Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma. Therapeutics and Clinical Risk Management 4:1, pages 205-211.
Read now

Articles from other publishers (5)

Rina Nabeta, Ami Kanaya, Mohamed Elbadawy, Tatsuya Usui, Tetsuya Furuya, Kazuhiko Suzuki & Tsuyoshi Uchide. (2023) Chemosensitivity of three patient-derived primary cultures of canine pericardial mesothelioma by single-agent and combination treatment. Frontiers in Veterinary Science 10.
Crossref
Jing Zeng, Ramesh Rengan & Charles R. ThomasJr.Jr.. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology 865 894.e8 .
Hidenori Ando, Sakiko Kobayashi, Amr S. Abu Lila, Noha Essam Eldin, Chihiro Kato, Taro Shimizu, Masami Ukawa, Kazuyoshi Kawazoe & Tatsuhiro Ishida. (2015) Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed. Journal of Controlled Release 220, pages 29-36.
Crossref
Ramesh Rengan, Lara P. Bonner Millar & Charles R. ThomasJr.Jr.. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology 859 889 .
Flora Guillot, Benoît Boutin, Christophe Blanquart, Jean-François Fonteneau, Myriam Robard, Marc Grégoire & Daniel Pouliquen. (2011) Vaccination with epigenetically treated mesothelioma cells induces immunisation and blocks tumour growth. Vaccine 29:33, pages 5534-5543.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.